Mr Andrew DenverBSc. (Hons), MBA, FAICD
Mr. Denver has extensive expertise that is relevant to the Company, including in assisting the commercialization of several technology companies. Mr. Denver has a wide ranging knowledge of the life sciences industry of which our Company is a part, including risk assessment, financial reporting experience and general managment, which are important in the success of our business. Mr. Denver currently serves as the Interim Chief Executive Office of the Company and has been a director of the Company since December 2002 and Chairman since September 2005. Mr. Denver has been a member of the Remuneration & Nomination Committee since January 2008 and, until July 2016, was a member of the Audit & Compliance Committee. Mr. Denver has served as a director of Universal Biosensors Pty Ltd, a wholly owned subsidiary of the Company, since December 2002. Between 2002 and 2005, Mr. Denver was President of Pall Asia, a subsidiary of Pall Corporation after the acquisition by Pall Corporation of US Filter's Filtration and Separation business, where he was also President. Pall Corporation is a technology based filtration, separation and purification multinational company. Mr. Denver was a director and founder of PFM Cornerstone Ltd, a company which helped commercialize Australian technology businesses predominately in the life sciences industry. Mr. Denver in a non-executive director of Vaxxas Pty Ltd, SpeeDx Pty Ltd and Cochlear Ltd, all of which are life sciences companies, and until September 2010 and October 2008, was a non-executive director of CathRx Ltd and Anzon Australia Ltd, respectively. Mr. Denver graduated from the University of Manchester with a Bachelor of Science Degree (Honors) in Chemistry and achieved a distinction in his M.B.A. at the Harvard Business School and is a Fellow of the Australian Institute of Company Directors.